CN102247586A - Medicine for treating asthma and preparation method thereof - Google Patents
Medicine for treating asthma and preparation method thereof Download PDFInfo
- Publication number
- CN102247586A CN102247586A CN2011102077057A CN201110207705A CN102247586A CN 102247586 A CN102247586 A CN 102247586A CN 2011102077057 A CN2011102077057 A CN 2011102077057A CN 201110207705 A CN201110207705 A CN 201110207705A CN 102247586 A CN102247586 A CN 102247586A
- Authority
- CN
- China
- Prior art keywords
- parts
- medicine
- herba
- asthma
- fructus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention discloses a medicine for treating asthma. The medicine is prepared by the following raw materials: ephedra stem, almond, perilla, cassia twigs, dried ginger, herba asaricum radice, Chinese magnoliavine, wolfberry, white peony root, honey-fried licorice root, Pinellia Tuber and cordate houttuynia. The medicine can be prepared into a plurality of drugs for clinical usage and is preferably to be capsules. The medicine provided in the invention has a good curative effect on a plurality of symptoms of asthma and is safe and reliable in clinical application.
Description
Technical field
The present invention relates to the medicine of a treatment asthma, specially referring to a kind of is the medicine of the treatment asthma of feedstock production with the Chinese herbal medicine, the invention still further relates to the preparation method of this medicine.
Background technology
In recent years, along with the change of life style and mode of operation, asthma has become a kind of disease of high incidence more, and asthma is universally acknowledged difficult medical problem, is classified as one of four big pertinacious diseases in the disease by World Health Organization (WHO).According to investigations, have 2,000 ten thousand above asthmatic patients at least, but have only the asthmatic patient of less than 5% to accept normalized treatment, should in time arrive examination in hospital, search the reason that causes asthma,, enhance your vigilance, as early as possible treatment in order to avoid incur loss through delay the diagnosis and treatment of protopathy in China.
The medicine of western medicine asthma is more at present, and most in the world at present chronic asthma patient treatment effects are undesirable.And Western medicine often is devoted to eliminate local symptom, and model of action is single, is difficult to accomplish to effect a radical cure the purpose of asthma, because the traditional Chinese medical science is in the especially unique achievement of treatment asthma, so often adopt the mode of the combination of Chinese and Western medicine to treat at present.
Summary of the invention
The present invention aims to provide the Chinese medicine of the treatment asthma that a kind of therapeutic effect is good, cost is low, have no side effect.
The preparation method that this medicine is provided is another goal of the invention of the present invention.
Medicine of the present invention is to be made by following quality proportion raw material:
Herba Ephedrae 5-15 part, Semen Armeniacae Amarum 10-15 part, Fructus Perillae 10-15 part, Ramulus Cinnamomi 8-12 part, Rhizoma Zingiberis 10-12 part, Herba Asari 2-6 part, Fructus Schisandrae Chinensis 10-15 part, Fructus Lycii 10-15 part, Radix Paeoniae Alba 12-15 part, Radix Glycyrrhizae Preparata 10-15 part, Rhizoma Pinelliae 10-15 part, Herba Houttuyniae 15-30 part.
The further quality proportioning of each component of medicine of the present invention is:
9 parts in Herba Ephedrae, 12 parts in Semen Armeniacae Amarum, 12 parts of Fructus Perillaes, 11 parts of Ramulus Cinnamomi, 11 parts of Rhizoma Zingiberiss, 4 parts of Herba Asaris, 12 parts of Fructus Schisandrae Chinensis, 12 parts of Fructus Lycii, 14 parts of the Radix Paeoniae Albas, 12 parts of Radix Glycyrrhizae Preparatas, 12 parts of the Rhizoma Pinelliaes, 22 parts of Herba Houttuyniae.
The medicine of above-mentioned each component can be made various medicaments and go up said medicament, and the preferred dosage form of the present invention is a capsule.
The concrete preparation method of medicine of the present invention is as follows:
Get the Chinese medicine mix homogeneously of above-mentioned mass fraction, add clear water, 0.5-2 at a simmer hour, fry in shallow oil 3 times repeatedly after, 3 decocting liquids are merged, filter, being condensed into relative density is the clear paste of 1-1.2 (50 ℃), after 50-60 ℃ of drying, is ground into 100-120 purpose medicated powder, in incapsulating, sterilization makes the capsule product.
The traditional Chinese medical science thinks that traditional medicine is thought: the lung being the dominator of QI, the kidney being the root of QI.When asthma was shown effect, the lung road can not main gas, and suffering from a deficiency of the kidney can not improving inspiration by invigorating kidney-QI, and then QI rising in reverse order is in last, and sends out in dyspnea with rapid respiration.The spleen is the source of growth and development, spleen deficiency generating phlegm, and the stagnation of phlegm air flue so see and breath with cough, is breathed hard.Therefore, asthma is kidney, lung, spleen, the disease of three void.Therefore need dialectical as the case may be executing to control, all medicine reasonable compatibilities in the prescription of the present invention, complementary collaborative, dialectical treatment has better curative effect for multiple asthma.
During treatment, this medicine was taken for three times morning, noon, the late branch.
Actual efficacy for checking medicine of the present invention, use medicine of the present invention and cooperate the clinical treatment asthma patient, 100 examples, result are cured 61 examples, and cure rate is 61%, 9 examples are clearly better, total effective rate 70%, clinical test results prove that curative effect of medication of the present invention is definite, and have no side effect, clinical practice is safe and reliable.Medicine of the present invention is cheaper than similar drug price.
The specific embodiment
Prepare raw material according to following weight:
Herba Ephedrae 9kg, Semen Armeniacae Amarum 12kg, Fructus Perillae 12kg, Ramulus Cinnamomi 11kg, Rhizoma Zingiberis 11kg, Herba Asari 4kg, Fructus Schisandrae Chinensis 12kg, Fructus Lycii 12kg, Radix Paeoniae Alba 14kg, Radix Glycyrrhizae Preparata 12kg, Rhizoma Pinelliae 12kg, Herba Houttuyniae 22kg.
Get above-mentioned Chinese medicine mix homogeneously, add clear water, fry in shallow oil repeatedly 3 times, fried in shallow oil 1.5 hours for the first time, for the second time and fried in shallow oil 1 hour for the third time, 3 decocting liquids are merged, filter, being condensed into relative density is the clear paste of 1-1.2 (50 ℃), after 50-60 ℃ of drying, be ground into 100-120 purpose medicated powder, in incapsulating, sterilization makes the capsule product.
Claims (4)
1. medicine for the treatment of asthma is characterized in that described medicine is the medicament of being made by following materials based on weight:
Herba Ephedrae 5-15 part, Semen Armeniacae Amarum 10-15 part, Fructus Perillae 10-15 part, Ramulus Cinnamomi 8-12 part, Rhizoma Zingiberis 10-12 part, Herba Asari 2-6 part, Fructus Schisandrae Chinensis 10-15 part, Fructus Lycii 10-15 part, Radix Paeoniae Alba 12-15 part, Radix Glycyrrhizae Preparata 10-15 part, Rhizoma Pinelliae 10-15 part, Herba Houttuyniae 15-30 part.
2. the medicine of treatment asthma according to claim 1 is characterized in that described medicine is the medicament of being made by following quality proportion raw material:
9 parts in Herba Ephedrae, 12 parts in Semen Armeniacae Amarum, 12 parts of Fructus Perillaes, 11 parts of Ramulus Cinnamomi, 11 parts of Rhizoma Zingiberiss, 4 parts of Herba Asaris, 12 parts of Fructus Schisandrae Chinensis, 12 parts of Fructus Lycii, 14 parts of the Radix Paeoniae Albas, 12 parts of Radix Glycyrrhizae Preparatas, 12 parts of the Rhizoma Pinelliaes, 22 parts of Herba Houttuyniae.
3. the medicine of treatment asthma according to claim 1 and 2 is characterized in that described medicament is a capsule.
4. the preparation method of treatment asthmatic medicament according to claim 3, it is characterized in that getting the crude drug mix homogeneously of above-mentioned mass fraction, add clear water, 0.5-2 at a simmer hour, after frying in shallow oil 3 times repeatedly, 3 decocting liquids are merged, filter, the clear paste that to be condensed into 50 ℃ of following relative densities be 1-1.2, after 50-60 ℃ of drying, be ground into 100-120 purpose medicated powder, in incapsulating, sterilization makes the capsule product.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2011102077057A CN102247586A (en) | 2011-07-23 | 2011-07-23 | Medicine for treating asthma and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2011102077057A CN102247586A (en) | 2011-07-23 | 2011-07-23 | Medicine for treating asthma and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN102247586A true CN102247586A (en) | 2011-11-23 |
Family
ID=44975389
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2011102077057A Pending CN102247586A (en) | 2011-07-23 | 2011-07-23 | Medicine for treating asthma and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102247586A (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103142949A (en) * | 2013-02-21 | 2013-06-12 | 成都科创佳思科技有限公司 | Chinese patent drug for treating infantile asthma |
CN103372142A (en) * | 2013-08-06 | 2013-10-30 | 天津太平洋制药有限公司 | Medicament for treating asthma |
CN103432563A (en) * | 2013-09-11 | 2013-12-11 | 延安职业技术学院 | Traditional Chinese medicine prescription for treating wind-cold type bronchial asthma |
CN104189868A (en) * | 2014-09-28 | 2014-12-10 | 王星月 | Traditional Chinese medicine for treating bronchial asthma |
CN105395746A (en) * | 2015-11-26 | 2016-03-16 | 龙启知 | Medicine for treating asthma in elderly |
CN105412866A (en) * | 2015-11-29 | 2016-03-23 | 张爱萍 | Cassia twig combined medicine for treating asthma in elderly |
CN106890255A (en) * | 2015-12-18 | 2017-06-27 | 上海理工大学 | A kind of asthma prescription |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1140087A (en) * | 1996-06-11 | 1997-01-15 | 王来运 | Liquid medicine for treatment of tracheitis and preparing method thereof |
CN101623494A (en) * | 2009-08-05 | 2010-01-13 | 王永珍 | Ephedra and perilla seed decoction for treating chronic bronchitis |
CN102100856A (en) * | 2009-12-17 | 2011-06-22 | 苏州知微堂生物科技有限公司 | Nano traditional Chinese medicine for treating bronchial asthma and preparation technology |
-
2011
- 2011-07-23 CN CN2011102077057A patent/CN102247586A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1140087A (en) * | 1996-06-11 | 1997-01-15 | 王来运 | Liquid medicine for treatment of tracheitis and preparing method thereof |
CN101623494A (en) * | 2009-08-05 | 2010-01-13 | 王永珍 | Ephedra and perilla seed decoction for treating chronic bronchitis |
CN102100856A (en) * | 2009-12-17 | 2011-06-22 | 苏州知微堂生物科技有限公司 | Nano traditional Chinese medicine for treating bronchial asthma and preparation technology |
Non-Patent Citations (2)
Title |
---|
刘莎等: "浅谈支气管哮喘的中医药研究", 《光明中医》 * |
彭波等: "中医药治疗支气管哮喘临床研究进展", 《辽宁中医杂志》 * |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103142949A (en) * | 2013-02-21 | 2013-06-12 | 成都科创佳思科技有限公司 | Chinese patent drug for treating infantile asthma |
CN103372142A (en) * | 2013-08-06 | 2013-10-30 | 天津太平洋制药有限公司 | Medicament for treating asthma |
CN103432563A (en) * | 2013-09-11 | 2013-12-11 | 延安职业技术学院 | Traditional Chinese medicine prescription for treating wind-cold type bronchial asthma |
CN104189868A (en) * | 2014-09-28 | 2014-12-10 | 王星月 | Traditional Chinese medicine for treating bronchial asthma |
CN105395746A (en) * | 2015-11-26 | 2016-03-16 | 龙启知 | Medicine for treating asthma in elderly |
CN105412866A (en) * | 2015-11-29 | 2016-03-23 | 张爱萍 | Cassia twig combined medicine for treating asthma in elderly |
CN106890255A (en) * | 2015-12-18 | 2017-06-27 | 上海理工大学 | A kind of asthma prescription |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102247586A (en) | Medicine for treating asthma and preparation method thereof | |
CN101658631A (en) | Drug for treating chronic bronchitis and pulmonary emphysema | |
CN100431570C (en) | Medicine for treating idiopathy thrombocytopenia peliosis | |
CN102657736B (en) | Medicament composition for treating rheumatoid arthritis and preparation method of medicament composition | |
CN101780251B (en) | Chinese traditional medicine composition for eliminating blood toxicity and improving blood viscosity and preparation method thereof | |
CN103301355A (en) | Preparation method of chronic renal failure colon dialysate | |
CN102198222B (en) | Medicament for treating anaphylactoid purpura | |
CN104173727A (en) | Medicine for treating toothache | |
CN102228624A (en) | Medicament for treating pharyngitis and preparation method thereof | |
CN102266451A (en) | Medicament for treating infantile eczema and preparation method thereof | |
CN103272030A (en) | Pneumonic treatment medicine and preparation method thereof | |
CN102764337A (en) | Traditional Chinese medicine composition for curing hepatitis B | |
CN103341126B (en) | Chinese medicine composite for treating chronic gastritis and preparation method thereof | |
CN103285128B (en) | Traditional Chinese medicine for treating bronchial asthma and preparation method thereof | |
CN101856423A (en) | Medicament for treating menoxenia and preparation method thereof | |
CN101856452A (en) | Medicament for treating bronchitis and preparation method thereof | |
CN102283981A (en) | Drug for curing hyperthyroidism and preparation method thereof | |
CN103006955B (en) | Traditional Chinese medicine composition for treating asthma | |
CN102366594A (en) | Traditional Chinese medicine for adjusting menstruation | |
CN102824461A (en) | Medicine for treating hypertension and preparation method thereof | |
CN102225119A (en) | Medicine for treating headache and preparation method thereof | |
CN103055118A (en) | Traditional Chinese medicine for treating asthma | |
CN102284023A (en) | Chinese medicinal composition for treating asthma | |
CN103721199A (en) | Traditional Chinese medicine decoction for treating panasthenia | |
CN101829213B (en) | Medicine composition for treating asthma and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20111123 |